28532107|t|Comparison of electrospun and solvent cast polylactic acid (PLA)/ poly(vinyl alcohol) (PVA) inserts as potential ocular drug delivery vehicles
28532107|a|The purpose of this work was to develop, characterize and compare electrospun nanofiber inserts (ENIs) and solvent cast polymeric inserts (SCIs) for ocular drug delivery. ENI and SCI of 1%, 5% and 10% w/w dexamethasone were fabricated using a blend of poly-lactic acid (PLA) and poly-vinyl alcohol (PVA). Inserts were characterized for morphology, thickness, pH, drug content, drug crystallinity, in vitro drug release, sterility, dimethylformamide (DMF) and chloroform content, and cytotoxicity. The thickness of 1%, 5%, and 10% dexamethasone -loaded ENIs were found to be 50μm, 62.5μm, and 93.3μm, respectively, with good folding endurance. SCIs were brittle, with thickness values >200μm. Drug release rates from 1%, 5% and 10% ENIs were found to be 0.62μg/h, 1.46μg/h, and 2.30μg/h, respectively, while those from SCIs were erratic. DMF content in ENIs and SCIs were 0.007% w/w and 0.123% w/w, respectively, while chloroform was not detected. No cytotoxicity was observed from ENIs in cultured bovine corneal endothelial cells for up to 24h. We conclude that ENIs are better than SCIs and could be utilized as a potential delivery system for treating anterior segment ocular diseases.
28532107	43	58	polylactic acid	T103	UMLS:C0071443
28532107	60	63	PLA	T103	UMLS:C0071443
28532107	66	85	poly(vinyl alcohol)	T103	UMLS:C0032623
28532107	87	90	PVA	T103	UMLS:C0032623
28532107	92	99	inserts	T103	UMLS:C0005479
28532107	113	119	ocular	T017	UMLS:C0015392
28532107	120	142	drug delivery vehicles	T103	UMLS:C0042444
28532107	231	238	inserts	T103	UMLS:C0005479
28532107	263	272	polymeric	T103	UMLS:C0032521
28532107	273	280	inserts	T103	UMLS:C0005479
28532107	282	286	SCIs	T103	UMLS:C0032521
28532107	292	298	ocular	T017	UMLS:C0015392
28532107	299	312	drug delivery	T074	UMLS:C0085104
28532107	322	325	SCI	T103	UMLS:C0032521
28532107	348	361	dexamethasone	T103	UMLS:C0011777
28532107	395	411	poly-lactic acid	T103	UMLS:C0071443
28532107	413	416	PLA	T103	UMLS:C0071443
28532107	422	440	poly-vinyl alcohol	T103	UMLS:C0032623
28532107	442	445	PVA	T103	UMLS:C0032623
28532107	448	455	Inserts	T103	UMLS:C0005479
28532107	574	591	dimethylformamide	T103	UMLS:C0012426
28532107	593	596	DMF	T103	UMLS:C0012426
28532107	602	612	chloroform	T103	UMLS:C0008238
28532107	626	638	cytotoxicity	T038	UMLS:C0596402
28532107	673	686	dexamethasone	T103	UMLS:C0011777
28532107	767	784	folding endurance	T033	UMLS:C0518031
28532107	786	790	SCIs	T103	UMLS:C0032521
28532107	796	803	brittle	T033	UMLS:C3810845
28532107	961	965	SCIs	T103	UMLS:C0032521
28532107	980	983	DMF	T103	UMLS:C0012426
28532107	1004	1008	SCIs	T103	UMLS:C0032521
28532107	1061	1071	chloroform	T103	UMLS:C0008238
28532107	1076	1088	not detected	T033	UMLS:C0442737
28532107	1090	1092	No	T033	UMLS:C1513916
28532107	1093	1105	cytotoxicity	T038	UMLS:C0596402
28532107	1132	1140	cultured	T017	UMLS:C0007635
28532107	1141	1147	bovine	T204	UMLS:C3667982
28532107	1148	1173	corneal endothelial cells	T017	UMLS:C0225336
28532107	1227	1231	SCIs	T103	UMLS:C0032521
28532107	1269	1284	delivery system	T074	UMLS:C0085104
28532107	1298	1314	anterior segment	T082	UMLS:C0348014
28532107	1315	1330	ocular diseases	T038	UMLS:C0015397